A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers.

author

  • Lally, Michelle Associate Professor of Medicine, Director of Brown AIDS Center (CFAR), Director of Brown University AIDS Program (BRUNAP), Associate Professor of Health Services, Policy and Practice